Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 6, 2003, Pages 1078-1087

  Park, Jung Won ^a   Taube, Christian ^a   Yang, Eun Seok ^a   Joetham, Anthony ^a   Balhorn, Annette ^a   Takeda, Katsuyuki ^a   Miyahara, Nobuaki ^a   Dakhama, Azzeddine ^a   Donaldson, Debra D ^b   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Airway hyperresponsiveness; IL 13; Respiratory syncytial virus

Indexed keywords

ALLERGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; METHACHOLINE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GOBLET CELL; KNOCKOUT MOUSE; LUNG LAVAGE; MEDIATOR RELEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENSITIZATION; VIRUS INDUCTION; VIRUS INFECTION;

EID: 10744223418     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.08.046     Document Type: Article

References (47)

1. Heilman CA. Respiratory syncytial virus and parainfluenza viruses. J Infect Dis 1990;161:402-6.
2. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:501-7.
3. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997;100:226-33.
4. Schwarze J, Cieslewicz G, Hamelmann E, Joetham A, Schultz LD, Lamers MC, et al. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol 1999;162:2997-3004.
5. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Mäkelä MJ, Dakhama A, et al. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med 2000;162:380-6.
6. Openshaw PJM, Clarke SL, Record FM. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface protein G. Int Immunol 1992;4:493-500.
7. Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virol 1996;70:2852-60.
8. Srikiatkhachorn A, Braciale TJ. Virus specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J Virol 1997;71:678-85.
9. + T cell response. J Immunol 2000;165:6487-95.
10. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61.
11. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick D, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-3.
12. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-88.
13. Walter DM, McIntire J, Berry G, Mckenzie ANJ, Donaldson DD, DeKruyff RH, et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167:4668-75.
14. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, et al. The role of IL-13 in established allergic airway disease. J Immunol 2002;169:6482-9.
15. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεR1. CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997;99:1492-9.
16. Li S, Sim TC, Alam R. IL-13 released by and localized in human basophils. J Immunol 1996;146:4833-8.
17. + Th0, Th1 and Th2 cell clones and EBV-transformed B cells. Intl J Immunol 1995;7:1405-16.
18. + 45RO-T cells develop into effector cells that secrete IL-13, IL-5, and IFN-γ, but not IL-4 and help efficient IgE production by B cells. J Immunol 1995;154:3078-87.
19. Whittaker L, Niu N, Temann UA, Stoddard A, Flavell RA, Ray A, et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and Interleukin-9. Am J Respir Cell Mol Biol 2002;27:593-602.
20. Tekkanat KK, Maassab HF, Cho DS, Lai JJ, John A, Berlin A, et al. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol 2001;166:3542-8.
21. Lukacs NW, Tekkanat KK, Berlin A, Hogaboam CM, Miller A, Evanoff H, et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001;167:1060-5.
22. Peebles RS, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Parker RA, et al. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. J Med Virol 2001;63:178-88.
23. Peebles RS, Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, et al. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges. J Infect Dis 2001;184:1374-9.
24. Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, et al. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J Immunol 1998;161:2317-24.
25. Mckenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998;9:423-32.
26. Mäkelä MJ, Kanehiro A, Dakhama A, Borish L, Joetham A, Tripp R, et al. The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am J Respir Crit Care Med 2002;165:824-31.
27. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997;186:449-54.
28. Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, Lee JJ, et al. Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997;155:819-25.
29. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An II-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999;104:777-85.
30. Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldon DD, Wynn TQ. IL-13 is a key regulator cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol 1999;162:920-30.
31. Bancroft AJ, Artis D, Donaldson DD, Sypek JP, Grencis RK. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent. Eur J Immunol 2000;30:2083-91.
32. Tomkinson A, Cieslewicz G, Duez C, Larson KA, Lee JJ, Gelfand EW. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med 2001;163:721-30.
33. Venkayya R, Lam M, Willkom M, Grünig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002;26:202-8.
34. Wu CA, Puddington L, Whiteley HE, Yiamouyiannis CA, Schramm CM, Mohammadu F, et al. Murine cytomegalovirus infection alters Th1/Th2 cytokine expression, decreases airway eosinophilia, and enhances mucus production in allergic airway disease. J Immunol 2001;167:2798-807.
35. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002;110:165-75.
36. Cohn L, Homer RJ, MacLeod H, Mohr M, Brombacher F, Bottomly K. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J Immunol 1999;162:6178-83.
37. Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and Interferon γ regulate allergic airway inflammation and mucus production. J Exp Med 1999;190:1309-17.
38. Vannier E, de Waal Malefyt R, Salazar-Montes A, de Vries JE. Dinarello CA. IL-13 induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein. Blood 1996;87:3307-15.
39. Isomaki P, Luukkainen R, Toivanen P, Punnonen J. The presence of interleukin-13 in rheumatoid asynovium and its anti-inflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1693-1702.
40. Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFNgamma, and IL-12 production. J Immunol 1997;158:2898-903.
41. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott D. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 1994;153:4258-67.
42. Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, et al. IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J Immunol 2000;164:3563-72.
43. Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 1996;26:2399-403.
44. Tekkanat KK, Maassab H, Berlin AA, Lincoln PM, Evanoff HL, Kaplan MH, et al. Role of interleukin-12 and Stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. Am J Pathol 2001;159:631-8.
45. Waris ME, Tsou C, Erdman DD, Day DB, Anderson LJ. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice previously immunized with formalin-inactivated RSV. J Virol 1997;71:6935-9.
46. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, et al. The role of 1FN in respiratory syncytial virus pathogenesis. J Immunol 2002;168:2944-51.
47. Prieto J, Lensmar C, Roquet A, van der Ploeg I, Gigliotti D, Ekund A, et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000;94:806-14.